Eli Lilly’s oral obesity treatment efficacy falls short of expectations, says BMO’s Evan SeigermanAugust 7, 2025
Share Facebook Twitter LinkedIn Pinterest Email CNBC’s MacKenzie Sigalos joins ‘Closing Bell Overtime’ with Block Q2 results.